CoChat

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4

Open access
Stewart-Jones, Guillaume B. E., Chuang, Gwo-Yu, Xu, Kai, Zhou, Tongqing, Acharya, Priyamvada, Tsybovsky, Yaroslav, Ou, Li, Zhang, Baoshan, Fernandez-Rodriguez, Blanca, Gilardi, Valentina, Silacci-Fregni, Chiara, Beltramello, Martina, Baxa, Ulrich, Druz, Aliaksandr, Kong, Wing-Pui, Thomas, Paul V., Yang, Yongping, Foulds, Kathryn E., Todd, John-Paul, Wei, Hui, Salazar, Andres M., Scorpio, Diana G., Carragher, Bridget, Potter, Clinton S., Corti, Davide, Mascola, John R., Lanzavecchia, Antonio, Kwong, Peter D. · 2018 · Proceedings of the National Academy of Sciences
Cited by 97

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Parainfluenza virus types 1–4 (PIV1–4) are highly infectious human pathogens, of which PIV3 is most commonly responsible for severe respiratory illness in newborns, elderly, and immunocompromised individuals. To obtain a vaccine effective against all four PIV types, we engineered mutations in each of the four PIV fusion (F) glycoproteins to stabilize their metastable prefusion states, as such stabilization had previously enabled the elicitation of high-titer neutralizing antibodies against the related respiratory syncytial virus. A cryoelectron microscopy structure of an engineered PIV3 F prefusion-stabilized trimer, bound to the prefusion-specific antibody PIA174, revealed atomic-level details for how introduced mutations improved stability as well as how a single PIA174 antibody recognized the trimeric apex of prefusion PIV3 F. Nine combinations of six newly identified disulfides and two cavity-filling mutations stabilized the prefusion PIV3 F immunogens and induced 200- to 500-fold higher neutralizing titers in mice than were elicited by PIV3 F in the postfusion conformation. For PIV1, PIV2, and PIV4, we also obtained stabilized prefusion Fs, for which prefusion versus postfusion titers were 2- to 20-fold higher. Elicited murine responses were PIV type-specific, with little cross-neutralization of other PIVs. In nonhuman primates (NHPs), quadrivalent immunization with prefusion-stabilized Fs from PIV1–4 consistently induced potent neutralizing responses against all four PIVs. For PIV3, the average elicited NHP titer from the quadrivalent immunization was more than fivefold higher than any titer observed in a cohort of over 100 human adults, highlighting the ability of a prefusion-stabilized immunogen to elicit especially potent neutralization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1811980115

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 97

Metadata

Authors
Stewart-Jones, G. B. E., Chuang, G.-Y., Xu, K., Zhou, T., Acharya, P., Tsybovsky, Y., Ou, L., Zhang, B., Fernandez-Rodriguez, B., Gilardi, V., Silacci-Fregni, C., Beltramello, M., Baxa, U., Druz, A., Kong, W.-P., Thomas, P. V., Yang, Y., Foulds, K. E., Todd, J.-P., Wei, H., Salazar, A. M., Scorpio, D. G., Carragher, B., Potter, C. S., Corti, D., Mascola, J. R., Lanzavecchia, A., & Kwong, P. D.
Venue
Proceedings of the National Academy of Sciences
Published
2018-11-12
Volume
115
Issue
48
Pages
12265-12270
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2901328586
Cited by
97
References
6
FWCI
5.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4. https://app.cochat.ai/papers/10.1073/pnas.1811980115
The paper
Stewart-Jones, G. B. E., Chuang, G.-Y., Xu, K., Zhou, T., Acharya, P., Tsybovsky, Y., Ou, L., Zhang, B., Fernandez-Rodriguez, B., Gilardi, V., Silacci-Fregni, C., Beltramello, M., Baxa, U., Druz, A., Kong, W.-P., Thomas, P. V., Yang, Y., Foulds, K. E., Todd, J.-P., . . . Kwong, P. D. (2018). Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1811980115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.